Both in Diagnostics
BIOMERICA vs Immucell
Over the past year BMRA returned −37.3% and ICCC returned +65.1%; their daily moves had a correlation of 0.03.
BMRA −37.3% ICCC +65.1%Growth of $1, one year, split-adjusted
| Metric | BMRA | ICCC |
|---|---|---|
| Price | $1.70 | $10.25 |
| Market cap | $7.8M | $93.1M |
| Today | −1.73% | −2.94% |
| 1 month | −17.1% | +5.1% |
| 6 months | −22.2% | +15.3% |
| Year to date | −32.5% | +66.7% |
| 1 year | −39.1% | +64.3% |
| Revenue growth (YoY) | −8.3% | +11.5% |
| Gross margin | 8.1% | 33.9% |
| Net margin | −97.4% | 25.5% |
| P/E (TTM) | — | 118.2× |
| Price / sales | 1.8× | 3.0× |
| Net cash | $2.7M | $557.3K |
| Dividend yield | — | — |
| Volatility (60d) | 72.1% | 38.3% |
| Short % of float | 0.3% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).